NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has acquired Israeli synthetic biology software company Genome Compiler.

Under the terms of the agreement, the Genome Compiler research and development center in Israel will remain open as Twist's first international site. Financial terms of the deal were not disclosed.

Twist said it plans to use Genome Compiler's technology and expertise to develop a digital products portfolio, including an e-commerce solution with gene design capabilities, which is expected to be available in the second half of 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.